Advances in the use of stem cells in orthopedics;Avanços no uso de células-tronco em ortopedia

Revista Brasileira de Ortopedia

Volumn 46, Issue 4, 2011, Pages 359-367

  Cristante, Alexandre Fogaça ^a   Narazaki, Douglas Kenji ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cartilage; orthopedics trends; pseudarthrosis; stem cells

Indexed keywords

EID: 80054958031     PISSN: 01023616     EISSN: 19824378     Source Type: Journal    
DOI: 10.1590/S0102-36162011000400003     Document Type: Article

References (67)

1. Forsberg EC, Bhattacharya D, Weissman IL. Hematopoietic stem cells: expression profiling and beyond. Stem Cell Rev. 2006;2(1):23-30. (Pubitemid 44195975)
2. Li Y, Chi XC, Li XX, Xu JC. Multipotency of human neural stem cells from fetal striatum. Neuroreport. 2008;19(17):1679-83.
3. de Barros Filho TE, de Oliveira RP, Tsanaclis AM, de Barros EM, Cristante AF, Palma RM, et al. An experimental model for the transplantation of fetal central nervous system cells to the injured spinal cord in rats. Ver Hosp Clin Fac Med Sao Paulo. 2002;57(6):257-64.
4. Braughler JM, Hall ED. Current application of "high-dose" steroid therapy for CNS injury. A pharmacological perspective. J Neurosurg. 1985;62(6):806-10. (Pubitemid 15009402)
5. Breasted JH. The Edwin Smith surgical papyrus. Chicago: University of Chicago Press; 1930.
6. Behrmann DL, Bresnahan JC, Beattie MS. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp Neurol. 1994;126(1):61-75. (Pubitemid 24131103)
7. Ducker TB, Hamit HF. Experimental treatments of acute spinal cord injury. J Neurosurg. 1969;30(6):693-7.
8. Faden Al, Salzman S. Pharmacological strategies in CNS trauma. Trends Pharmacol Sci. 1992;13(1):29-35.
9. Tator CH, Rowed DW. Current concepts in the immediate management of acute spinal cord injuries. Can Med Assoc J. 1979;121 (11):1453-64. (Pubitemid 10199426)
10. Young W, DeCrescito V, Flamm ES, Blight AR, Gruner JA. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone. Clin Neurosurg. 1988;34:675-97.
11. Allen AR. Remarkes on histopathological changes in spinal cord due to impact: an experimental study. J Nerv Ment Dis. 1914;41:141-7.
12. Allen AR. Surgery of experimental lesions of spinal cord equivalent to crush injury of fracture dislocation. Preliminary report. J Am Med Assoc. 1911;57:878-80.
13. Anderson DK, Means ED, Waters TR, Spears CJ. Spinal cord energy metabolism following compression trauma to the feline spinal cord. J Neurosurg. 1980;53(3):375-80. (Pubitemid 10052158)
14. Balentine JD. Hypotheses in spinal cord trauma research. In: Becker DP, Po- vlishock J T, editors. Central nervous system trauma status report. Bethesda: NIH; 1985. p. 455-61.
15. Balentine JD. Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab Invest. 1978;39(3):254-66. (Pubitemid 9025480)
16. Demopoulos HB, Flamm ES, Pietronigro DD, Seligman ML. The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand Suppl. 1980;492:91-119. (Pubitemid 11152702)
17. Dohrmann GJ, Wagner FC, Bucy PC. The microvasculature in transitory traumatic paraplegia. An electron microsopic study in the monkey. J Neurosurg. 1971;35:263-71.
18. Goodkin R, Campbell JB. Sequencial pathological changes in spinal cord injury: a preliminary report. Surg Forum. 1996;20:430-2.
19. SpillerWG. A microscopic study of the spinal cord in two cases of Pott's disease. Bulletin of the Johns Hopkins Hosp. 1898;9:125-33.
20. Noble LJ, Wrathall JR. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res. 1989;482(1):57-66. (Pubitemid 19063150)
21. Wagner FC Jr, VanGilder JC, Dohrmann GJ. Pathological changes from acute to chronic in experimental spinal cord trauma. J Neurosurg. 1978;48(1):92-8. (Pubitemid 8260324)
22. Seshi B, Kumar S, Sellers D. Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells Mol Dis. 2000;26(3):234-46.
23. Ducker TB, Salcman M, Perot PL Jr, Ballantine D. Experimental spinal cord trauma, I: Correlation of blood flow, tissue oxygen and neurologic status in the dog. Surg Neurol. 1978;10(1):60-3. (Pubitemid 8369668)
24. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci. 1994;6(5):712-24. (Pubitemid 24143919)
25. Green BA, Wagner FC Jr. Evolution of edema in the acutely injured spinal cord: a fluorescence microscopic study. Surg Neurol. 1973;1(2):98-101.
26. Herrick MK, Mills PE Jr. Infarction of spinal cord. Two cases of selective gray matter involvement secondary to asymptomatic aortic disease. Arch Neurol. 1971;24(3):228-41.
27. Holtz A, Nystrbm B, Gerdin B. Spinal cord blood flow measured by 14C-iodo- antipyrine autoradiography during and after graded spinal cord compression in rats. Surg Neurol. 1989;31(5):350-60. (Pubitemid 19127511)
28. Janssen L, Hansebout RR. Pathogenesis of spinal cord injury and newer treatments. A review. Spine (Phila Pa 1976). 1989;14(1):23-32. (Pubitemid 19044933)
29. Rivlin AS, Tator CH. Regional spinal cord blood flow in rats after severe cord trauma. J Neurosurg. 1978;49(6):844-53. (Pubitemid 9062913)
30. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75(1):15-26.
31. Faden Al, Ellison JA, Noble LJ. Effects of competitive and non-competitive NMDA receptor antagonists in spinal cord injury. Eur J Pharmacol. 1990;175(2):165-74. (Pubitemid 20030154)
32. Faden Al, Jacobs TP, Mougey E, Holaday JW. Endorphins in experimental spinal injury: therapeutic effect of naloxone. Ann Neurol. 1981 ;10(4):326-32. (Pubitemid 11027069)
33. Luer MS, Rhoney DH, Hughes M, Hatton J. New pharmacologic strategies for acute neuronal injury. Pharmacotherapy. 1996;16(5):830-48. (Pubitemid 26322186)
34. Young W, Flamm ES, Demopoulos HB, Tomasula JJ, DeCrescito V. Effect of naloxone on posttraumatic ischemia in experimental spinal contusion. J Neurosurg. 1981;55(2):209-19. (Pubitemid 11034235)
35. Anderson DK, Means ED, Waters TR, Green ES. Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment. J Neurosurg. 1982;56(1):106-13. (Pubitemid 12092617)
36. Bracken MB. Pharmacological treatment of acute spinal cord injury: current status and future projects. J Emerg Med. 1993;11(Suppl 1):43-8. (Pubitemid 23054998)
37. Braughler JM, Hall ED. Pharmacokinetics of methylprednisolone in cat plasma and spinal cord following a single intravenous dose of the sodium succinate ester. Drug Metab Dispos. 1982;10(5):551-2.
38. Braughler JM, Hall ED. Lactate and pyruvate metabolism in injured cat spinal cord before and after a single large intravenous dose of methylprednisolone. J Neurosurg. 1983;59(2):256-61. (Pubitemid 13029204)
39. De Ley G, Leybaert L. Effect of flunarizine and methylprednisolone on functional recovery after experimental spinal injury. J Neurotrauma. 1993;10(1):25-35. (Pubitemid 23153143)
40. Hall ED, Braughler JM. Acute effects of intravenous glucocorticoid pre- treatment on the in vitro peroxidation of cat spinal cord tissue. Exp Neurol. 1981;73(1):321-4. (Pubitemid 11039791)
41. Hall ED. The effects of glucocorticoid and nonglucocorticoid steroids on acute neuronal degeneration. In: Sell FJ, editor. Advances in neurology. New York: Raven; 1993. p. 241-8.
42. Hall ED, Braughler JM. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and Na+ + K+)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J Neurosurg. 1982;57(2):247-53. (Pubitemid 12099610)
43. Hall ED, Wolf DL, Braughler JM. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis. J Neurosurg. 1984;61(1):124-30. (Pubitemid 14081301)
44. Hall ED, McCall JM, Chase RL, Yonkers PA, Braughler JM. A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J Pharmacol Exp Ther. 1987;242(1):137-42. (Pubitemid 17112271)
45. Hall ED, Yonkers PA, Andrus PK, Cox JW, Anderson DK. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma. 1992;9(Suppl 2):S425-42.
46. Means ED, Anderson DK, Waters TR, Kalaf L. Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg. 1981;55(2):200-8. (Pubitemid 11034234)
47. Richardson HD, Nakamaura S. An electron microscopic study of spinal cord edema and the effect of treatment with steroids, mannitol, and hypothermia. Proc Veterans Adm Spinal Cord Inj Conf. 1971;18:10-6.
48. Anderson DK, Braughler JM, Hall ED, Waters TR, McCall JM, Means ED. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury. J Neurosurg. 1988;69(4):562-7.
49. Hall ED. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats. J Neurosurg. 1988;68(3):462-5. (Pubitemid 18067648)
50. Cuello AC, Garofalo L, Kenigsberg RL, Maysinger D. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc Natl Acad Sci USA. 1989;86(6):2056-60. (Pubitemid 19087067)
51. Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal- cord injury-a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med. 1991; 324(26):1829-38.
52. Geisler FH, Dorsey FC, Coleman WP. Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury. Ann Emerg Med. 1993;22(6):1041-7. (Pubitemid 23163048)
53. Gorio A. Gangliosides as a possible treatment affecting neuronal repair processes. In: Waxman SG, editor. Advances in neurology: functional recovery in neurological disease. New York: Raven; 1988. p. 523-30.
54. Karpiak SE, Wakade CG, Tagliavia A, Mahadik SP. Temporal changes in edema, Na+, K+, and Ca++ in focal cortical stroke: GM1 ganglioside reduces ischemic injury. J Neurosci Res. 1991;30(3):512-20.
55. Mahadik SP, Hawver DB, Hungund BL, Li YS, Karpiak SE. GM1 ganglioside treatment after global ischemia protects changes in membrane fatty acids and properties of Na+, K+-ATPase and Mg2+-ATPase. J Neurosci Res. 1989;24(3):402-12. (Pubitemid 20001453)
56. Walker JB, Harris M. GM-1 ganglioside administration combined with physical therapy restores ambulation in humans with chronic spinal cord injury. Neurosci Lett. 1993;161(2):174-8. (Pubitemid 23314861)
57. Young W. Recovery mechanisms in spinal cord injury: implications for regenerative therapy. In Seil AJ. Neural regeneration and transplantation. New York: Alan Liss; 1995. p. 157-9.
58. Nagase T, Muneta T, Ju YJ, Hara K, Morito T, Koga H, et al. Analysis of the chondrogenic potential of human synovial stem cells according to harvest site and culture parameters in knees with medial compartment osteoarthritis. Arthritis Rheum. 2008;58(5):1389-98. (Pubitemid 351705928)
59. Cristante AF, Barros-Filho TE, Tatsui N, Mendrone A, Caldas JG, Camargo A, et al. Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord. 2009;47(10):733-8.
60. Corvol MT. [Cell therapy and its clinical applications. Cartilage cell therapy, present and future]. J Soc Biol. 2001 ;195(1):79-82.
61. Barry FR Mesenchymal stem cell therapy in joint disease. Novartis Found Symp. 2003.
62. Ogueta S, Munoz J, Obregon E, Delgado-Baeza E, Garcia-Ruiz JP. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Mol Cell Endocrinol. 2002;190(1-2):51-63. (Pubitemid 34462051)
63. Fukumoto T, Sperling JW, Sanyal A, Fitzsimmons JS, Reinholz GG, Conover CA, et al. Combined effects of insulin-like growth factor-1 and transforming growth factor-betal on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage. 2003;11(1):55-64. (Pubitemid 36157574)
64. Rahaman MN, Mao JJ. Stem cell-based composite tissue constructs for regenerative medicine. Biotechnol Bioeng. 2005;91(3):261-84. (Pubitemid 41076840)
65. Hernigou P, Beaujean F. [Bone marrow in patients with pseudarthrosis. A study of progenitor cells by in vitro cloning]. Rev Chir Orthop Reparatrice Appar Mot. 1997;83(1):33-40.
66. Cetrulo CL Jr, Knox KR, Brown DJ, Ashinoff RL, Dobryansky M, Ceradini DJ, et al. Stem cells and distraction osteogenesis: endothelial progenitor cells home to the ischemic generate in activation and consolidation. Plast Reconstr Surg. 2005;116(4):1053-64. (Pubitemid 41324925)
67. Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, et al. Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc. 2006;14(12):1307-14. (Pubitemid 44800660)